Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancer

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

1989 • 1,003 citations

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.

1989 • 493 citations

Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer Cells

1988 • 353 citations

Cardiorespiratory effects of immunotherapy with interleukin-2.

1989 • 246 citations

The Hemodynamic Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

1988 • 118 citations

Myocardial Toxic Effects During Recombinant Interleukin-2 Therapy

1989 • 80 citations

Pathologic findings associated with interleukin-2—Based immunotherapy for cancer: A postmortem study of 19 patients

1990 • 62 citations

Severe myocarditis following high-dose interleukin-2 administration.

1989 • 52 citations

Interleukin 2 stimulates heart contractility in the presence of exogenous arachidonate or the calcium ionophore A 23187

1988 • 6 citations